Instructions for Gaviscon Double action (Sodium alginate, bicarbonate, calcium carbonate)
Suspension release form:
susp. d/ingestion (mint) 500 mg+267 mg+160 mg/10 ml: fl 150 ml or 300 ml
Description Gaviscon:
The infusion suspension (mint) is viscous, opaque, from almost white to creamy, with a mint smell.
10ml
alginate sodium 500 mg
sodium hydrogen carbonate 267 mg
calcium carbonate 160 mg
Auxiliary substances:
- carbomer - 65 mg,
- methylparahydroxybenzoate - 40 mg,
- propyl parahydroxybenzoate - 6 mg,
- sodium saccharinate - 10 mg,
- peppermint oil - 1 mg,
- sodium hydroxide - 26.667 mg,
- water purified - up to 10 ml.
English product name
Gaviscon Double Action
Release form
tabletop chewing (mint) 250 mg+106.5 mg+187.5 mg: 12 or 24 pcs
Description:
Tablets chewing (mint) round, flat, double-layer, with beveled edges and mint smell; One layer is pink and slightly darker, the other white; with a circle and a sword on one side of the pill and "GDA250" on the other.
1 tab.
alginate sodium 250 mg
sodium hydrogen carbonate 106.5 mg
calcium carbonate 187.5 mg
Auxiliary substances: mannitol - 598.799 mg, macrogol 20 000 - 30 mg, copovidone - 33.75 mg, potassium acetulpham - 5.863 mg, aspartame - 5.863 mg, azorubin dye (11012) - 0.375 mg, mint flavoring - 18.75 mg, xylitol (DC) - 100 mg, magnesium stearate - 6.75-12.6 mg.
ATC codes
A02BX Other anti-ulcer drugs
Clinical-pharmacological groups / Group affiliation
Antacid preparation
Active substance
calcium carbonate
sodium hydrogen carbonate
alginate sodium
Pharmacotherapy group:
Reflux esophagitis treatment
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 30 ° C.
Best before date
Shelf life is 2 years. Do not use the drug with an expired shelf life.
Testimony Gaviscon:
- Treatment of gastroesophageal reflux symptoms such as acid bursting,
- heartburn,
- dyspepsia,
- and stomach heaviness after eating,
- in patients with acidity of gastric juice or in pregnancy.
Method of use, course and dosage Gaviscon:
The drug is taken inside. The tablet should be thoroughly chewed.
Adults and children over 12 years old are given 2-4 tabas after eating and before going to bed (up to 4 times per day).
The maximum daily dose is 16 tabs.
The syrup is applied inside.
Adults and children over 12 years old are given 10-20 ml of suspensions after eating and before going to bed. The maximum daily dose is 80 ml.
Children aged six to twelve years are given 5-10 ml each after eating and before bed. The maximum daily dose is 40 ml.
Do not use the drug for a long time.
Application for kidney disorders
The use of the preparation is contraindicated in moderate to severe renal insufficiency.
With caution, you should use the drug for nephrocalcinosis and urolithiasis with the formation of oxalate stones, kidney failure is mild.
Use in liver disorders
No data.
Terms of Sale
The drug is released without a prescription.
Application in elderly patients
For elderly patients, no dose change is required.
Use in children
The use of the preparation in children under 12 years of age is contraindicated.
- Nosology Gaviscon (ICD codes)
- K21
- Gastroesophageal reflux
- K30
- Functional dyspepsia (digestive disorder)
- O99.6
- Digestive diseases complicating pregnancy, childbirth and the postpartum period
- R12
- Izzhoga
Pharmacological effect Gaviscon:
Gaviscon® Double Action is a combination of alginate and antacids (calcium carbonate and sodium hydrogen carbonate).
When ingested, the active substances of the drug react quickly with the acidic content of the stomach. This forms an alginate gel, which has an almost neutral pH value. The gel forms a protective barrier on the surface of the stomach contents, preventing the appearance of gastroesophageal reflux. In the case of regurgitation, the gel is more likely to enter the oesophagus, where it reduces mucous membrane irritation.
Calcium carbonate quickly neutralizes the hydrochloric acid of gastric juice, easing the sensation of heartburn and digestive disturbance. This effect is enhanced by the presence of hydrogen carbonate in the composition of the sodium preparation, which also has a neutralizing effect. The total acid-neutralizing activity of the preparation in the minimum dose (2 tabs.) is approximately 10 mEcv.